| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Wound Infection | 22 | 2024 | 202 | 11.630 |
Why?
|
| Anastomotic Leak | 27 | 2024 | 104 | 11.460 |
Why?
|
| Pseudomonas aeruginosa | 36 | 2021 | 203 | 8.960 |
Why?
|
| Sepsis | 30 | 2025 | 329 | 8.820 |
Why?
|
| Gastrointestinal Microbiome | 27 | 2025 | 520 | 6.760 |
Why?
|
| Intestinal Mucosa | 45 | 2017 | 806 | 5.850 |
Why?
|
| Intestines | 29 | 2023 | 416 | 5.430 |
Why?
|
| Microbiota | 17 | 2024 | 407 | 5.320 |
Why?
|
| Anti-Bacterial Agents | 24 | 2025 | 798 | 5.030 |
Why?
|
| Enterococcus faecalis | 12 | 2022 | 54 | 4.210 |
Why?
|
| Colon | 17 | 2023 | 521 | 4.160 |
Why?
|
| Digestive System Surgical Procedures | 8 | 2023 | 128 | 3.780 |
Why?
|
| Anastomosis, Surgical | 22 | 2023 | 277 | 3.690 |
Why?
|
| Pseudomonas Infections | 14 | 2019 | 99 | 3.660 |
Why?
|
| Obesity, Morbid | 24 | 2010 | 241 | 3.570 |
Why?
|
| Phosphates | 13 | 2022 | 161 | 3.320 |
Why?
|
| Virulence | 27 | 2020 | 282 | 3.210 |
Why?
|
| Bacteria | 14 | 2020 | 486 | 2.950 |
Why?
|
| Preoperative Care | 9 | 2021 | 395 | 2.870 |
Why?
|
| Polyethylene Glycols | 14 | 2020 | 360 | 2.740 |
Why?
|
| Bariatric Surgery | 14 | 2020 | 200 | 2.620 |
Why?
|
| Wound Healing | 9 | 2020 | 361 | 2.600 |
Why?
|
| Gastrointestinal Tract | 10 | 2023 | 192 | 2.580 |
Why?
|
| Gastric Bypass | 17 | 2010 | 113 | 2.500 |
Why?
|
| Colectomy | 7 | 2024 | 175 | 2.460 |
Why?
|
| Postoperative Complications | 18 | 2024 | 2313 | 2.420 |
Why?
|
| Collagenases | 7 | 2022 | 41 | 2.410 |
Why?
|
| Critical Illness | 16 | 2021 | 311 | 2.340 |
Why?
|
| Diet, Western | 5 | 2023 | 38 | 2.250 |
Why?
|
| Humans | 176 | 2024 | 89924 | 2.200 |
Why?
|
| Disease Models, Animal | 17 | 2025 | 2393 | 2.190 |
Why?
|
| Mice, Inbred C57BL | 26 | 2025 | 3252 | 2.040 |
Why?
|
| Animals | 93 | 2025 | 27526 | 2.020 |
Why?
|
| Antibiotic Prophylaxis | 5 | 2024 | 77 | 2.010 |
Why?
|
| Cecum | 17 | 2025 | 73 | 1.970 |
Why?
|
| Hernia, Hiatal | 3 | 2024 | 38 | 1.930 |
Why?
|
| Fecal Microbiota Transplantation | 5 | 2025 | 69 | 1.900 |
Why?
|
| Mice | 49 | 2025 | 11851 | 1.870 |
Why?
|
| Adhesins, Bacterial | 8 | 2012 | 36 | 1.780 |
Why?
|
| Lectins | 8 | 2012 | 84 | 1.750 |
Why?
|
| Elective Surgical Procedures | 4 | 2020 | 129 | 1.560 |
Why?
|
| Bacterial Infections | 3 | 2018 | 184 | 1.450 |
Why?
|
| Plasminogen | 2 | 2021 | 45 | 1.440 |
Why?
|
| Asepsis | 2 | 2020 | 2 | 1.420 |
Why?
|
| Bacterial Adhesion | 20 | 2013 | 84 | 1.350 |
Why?
|
| Stress, Physiological | 11 | 2016 | 232 | 1.330 |
Why?
|
| Pancreatitis, Acute Necrotizing | 4 | 2020 | 18 | 1.320 |
Why?
|
| Macrophages | 3 | 2025 | 582 | 1.300 |
Why?
|
| Surgical Stapling | 3 | 2023 | 17 | 1.290 |
Why?
|
| Iron | 4 | 2018 | 168 | 1.290 |
Why?
|
| Feces | 8 | 2020 | 332 | 1.280 |
Why?
|
| Diet | 7 | 2023 | 444 | 1.280 |
Why?
|
| Intraabdominal Infections | 2 | 2020 | 10 | 1.260 |
Why?
|
| Host-Pathogen Interactions | 6 | 2022 | 237 | 1.250 |
Why?
|
| Gene Expression Regulation, Bacterial | 6 | 2018 | 217 | 1.240 |
Why?
|
| Dysbiosis | 4 | 2024 | 81 | 1.160 |
Why?
|
| Nutritional Status | 5 | 2023 | 81 | 1.120 |
Why?
|
| Antimicrobial Stewardship | 2 | 2024 | 23 | 1.110 |
Why?
|
| Laparoscopy | 8 | 2021 | 780 | 1.110 |
Why?
|
| Caenorhabditis elegans | 10 | 2016 | 231 | 1.100 |
Why?
|
| Malnutrition | 3 | 2023 | 33 | 1.090 |
Why?
|
| Colorectal Surgery | 3 | 2023 | 22 | 1.070 |
Why?
|
| Immunity | 4 | 2021 | 141 | 1.060 |
Why?
|
| Colorectal Neoplasms | 6 | 2023 | 980 | 1.050 |
Why?
|
| Infection Control | 3 | 2023 | 124 | 1.020 |
Why?
|
| Food, Formulated | 4 | 2021 | 24 | 1.020 |
Why?
|
| Herniorrhaphy | 2 | 2024 | 91 | 1.010 |
Why?
|
| Drug Resistance, Bacterial | 5 | 2022 | 76 | 0.980 |
Why?
|
| Enterobactin | 1 | 2025 | 5 | 0.980 |
Why?
|
| RNA, Ribosomal, 16S | 9 | 2021 | 251 | 0.980 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2025 | 20 | 0.970 |
Why?
|
| Analgesics, Opioid | 3 | 2016 | 451 | 0.960 |
Why?
|
| Nutritional Support | 4 | 2021 | 16 | 0.960 |
Why?
|
| Retirement | 1 | 2024 | 12 | 0.940 |
Why?
|
| Weight Loss | 15 | 2010 | 233 | 0.920 |
Why?
|
| Hepatectomy | 8 | 2018 | 172 | 0.920 |
Why?
|
| Male | 61 | 2024 | 42657 | 0.900 |
Why?
|
| Critical Care | 6 | 2021 | 384 | 0.900 |
Why?
|
| Tranexamic Acid | 2 | 2021 | 37 | 0.900 |
Why?
|
| Butyrates | 3 | 2020 | 46 | 0.890 |
Why?
|
| Rectal Fistula | 1 | 2023 | 18 | 0.890 |
Why?
|
| Recurrence | 4 | 2024 | 1145 | 0.890 |
Why?
|
| Alkaline Phosphatase | 1 | 2023 | 132 | 0.880 |
Why?
|
| Collagen | 4 | 2021 | 294 | 0.880 |
Why?
|
| Gastrectomy | 4 | 2020 | 71 | 0.870 |
Why?
|
| Morphine | 2 | 2016 | 130 | 0.870 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2023 | 83 | 0.850 |
Why?
|
| Surgical Procedures, Operative | 3 | 2018 | 206 | 0.840 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 103 | 0.830 |
Why?
|
| Intestine, Small | 5 | 2013 | 299 | 0.820 |
Why?
|
| Thinking | 1 | 2022 | 35 | 0.820 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2020 | 86 | 0.820 |
Why?
|
| Wounds and Injuries | 3 | 2024 | 264 | 0.820 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2022 | 46 | 0.800 |
Why?
|
| Rectum | 2 | 2021 | 148 | 0.800 |
Why?
|
| Anastomosis, Roux-en-Y | 5 | 2006 | 26 | 0.780 |
Why?
|
| Drinking Water | 1 | 2022 | 67 | 0.770 |
Why?
|
| Surgical Flaps | 1 | 2024 | 250 | 0.770 |
Why?
|
| Immunoglobulin A, Secretory | 11 | 1997 | 18 | 0.760 |
Why?
|
| Polyphosphates | 2 | 2018 | 7 | 0.760 |
Why?
|
| Bacillus subtilis | 2 | 2020 | 89 | 0.740 |
Why?
|
| Pancreatitis | 1 | 2021 | 86 | 0.740 |
Why?
|
| Dietary Fiber | 3 | 2021 | 44 | 0.740 |
Why?
|
| Peer Review | 1 | 2021 | 23 | 0.740 |
Why?
|
| Obesity | 6 | 2019 | 972 | 0.730 |
Why?
|
| Epithelial Cells | 8 | 2017 | 689 | 0.730 |
Why?
|
| Gastroesophageal Reflux | 2 | 2014 | 125 | 0.710 |
Why?
|
| Peer Group | 1 | 2021 | 86 | 0.690 |
Why?
|
| Fascia | 2 | 2021 | 31 | 0.680 |
Why?
|
| Diet, Fat-Restricted | 1 | 2019 | 31 | 0.680 |
Why?
|
| Rats | 24 | 2020 | 4048 | 0.680 |
Why?
|
| Quality Improvement | 1 | 2024 | 457 | 0.680 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2015 | 0.680 |
Why?
|
| Collagen Type IV | 1 | 2019 | 26 | 0.680 |
Why?
|
| Rectal Neoplasms | 1 | 2021 | 129 | 0.680 |
Why?
|
| Serratia marcescens | 2 | 2020 | 5 | 0.670 |
Why?
|
| Fibrinolysis | 1 | 2019 | 37 | 0.670 |
Why?
|
| Acinetobacter baumannii | 2 | 2017 | 29 | 0.660 |
Why?
|
| Collagen Type I | 1 | 2019 | 72 | 0.660 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2013 | 52 | 0.660 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 51 | 0.650 |
Why?
|
| Faculty | 1 | 2019 | 33 | 0.650 |
Why?
|
| Enterocolitis, Necrotizing | 4 | 2013 | 80 | 0.650 |
Why?
|
| Efficiency | 1 | 2019 | 40 | 0.640 |
Why?
|
| Colonic Diseases | 1 | 2019 | 61 | 0.640 |
Why?
|
| Surgical Wound | 1 | 2018 | 6 | 0.640 |
Why?
|
| Candida albicans | 3 | 2014 | 32 | 0.630 |
Why?
|
| Bulimia | 6 | 2007 | 142 | 0.620 |
Why?
|
| Ileostomy | 3 | 2016 | 29 | 0.590 |
Why?
|
| Phenols | 2 | 2015 | 41 | 0.590 |
Why?
|
| Treatment Outcome | 18 | 2024 | 8270 | 0.580 |
Why?
|
| Enterocolitis | 1 | 2017 | 13 | 0.570 |
Why?
|
| Wound Infection | 1 | 2017 | 17 | 0.570 |
Why?
|
| Smoke | 1 | 2017 | 27 | 0.570 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 78 | 0.560 |
Why?
|
| Acinetobacter Infections | 1 | 2017 | 18 | 0.560 |
Why?
|
| Mice, Inbred BALB C | 11 | 2023 | 1091 | 0.550 |
Why?
|
| Caco-2 Cells | 10 | 2011 | 123 | 0.550 |
Why?
|
| Quorum Sensing | 5 | 2013 | 28 | 0.550 |
Why?
|
| Carbon Monoxide | 1 | 2017 | 93 | 0.550 |
Why?
|
| Penicillanic Acid | 1 | 2016 | 11 | 0.540 |
Why?
|
| Debridement | 2 | 2011 | 59 | 0.540 |
Why?
|
| Polymers | 2 | 2022 | 196 | 0.540 |
Why?
|
| Female | 59 | 2024 | 46571 | 0.540 |
Why?
|
| Intestinal Diseases | 3 | 2016 | 79 | 0.540 |
Why?
|
| Cephalosporins | 1 | 2016 | 24 | 0.530 |
Why?
|
| Risk Factors | 10 | 2024 | 5554 | 0.530 |
Why?
|
| Operating Rooms | 1 | 2017 | 125 | 0.520 |
Why?
|
| Rectus Abdominis | 3 | 2024 | 40 | 0.510 |
Why?
|
| Gastrointestinal Transit | 1 | 2015 | 19 | 0.510 |
Why?
|
| Health Status | 3 | 2016 | 371 | 0.510 |
Why?
|
| Biomedical Research | 2 | 2019 | 404 | 0.500 |
Why?
|
| Random Allocation | 7 | 2018 | 327 | 0.500 |
Why?
|
| Duodenum | 4 | 2009 | 105 | 0.500 |
Why?
|
| Phenotype | 9 | 2022 | 2457 | 0.500 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 272 | 0.490 |
Why?
|
| Adult | 38 | 2024 | 26810 | 0.490 |
Why?
|
| Biofilms | 5 | 2018 | 46 | 0.490 |
Why?
|
| Burns | 1 | 2017 | 141 | 0.490 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 644 | 0.490 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 319 | 0.480 |
Why?
|
| Surgeons | 1 | 2019 | 249 | 0.480 |
Why?
|
| Malabsorption Syndromes | 2 | 2016 | 21 | 0.480 |
Why?
|
| Opportunistic Infections | 2 | 2012 | 60 | 0.480 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 185 | 0.470 |
Why?
|
| Rats, Wistar | 4 | 2016 | 303 | 0.470 |
Why?
|
| Cell Membrane Permeability | 3 | 2013 | 120 | 0.470 |
Why?
|
| Models, Animal | 5 | 2019 | 277 | 0.470 |
Why?
|
| Histamine H2 Antagonists | 1 | 2014 | 15 | 0.470 |
Why?
|
| Virulence Factors | 4 | 2017 | 112 | 0.470 |
Why?
|
| Thiazoles | 1 | 2015 | 127 | 0.470 |
Why?
|
| Metagenome | 3 | 2013 | 105 | 0.460 |
Why?
|
| Cytostatic Agents | 1 | 2013 | 4 | 0.460 |
Why?
|
| Ileum | 4 | 2012 | 168 | 0.460 |
Why?
|
| Proton Pump Inhibitors | 1 | 2014 | 34 | 0.450 |
Why?
|
| Candidiasis | 1 | 2013 | 37 | 0.440 |
Why?
|
| Precision Medicine | 1 | 2018 | 413 | 0.440 |
Why?
|
| Mutation | 4 | 2016 | 4165 | 0.440 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2011 | 52 | 0.430 |
Why?
|
| Monosaccharides | 1 | 2013 | 1 | 0.430 |
Why?
|
| Oxidants | 3 | 2012 | 86 | 0.430 |
Why?
|
| Apoptosis | 7 | 2017 | 1718 | 0.420 |
Why?
|
| Middle Aged | 33 | 2024 | 26132 | 0.420 |
Why?
|
| Escherichia coli | 5 | 2001 | 607 | 0.420 |
Why?
|
| Bile Acids and Salts | 2 | 2020 | 67 | 0.420 |
Why?
|
| Body Image | 6 | 2010 | 80 | 0.410 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 1352 | 0.410 |
Why?
|
| Peritonitis | 1 | 2012 | 29 | 0.410 |
Why?
|
| Retrospective Studies | 14 | 2023 | 9203 | 0.400 |
Why?
|
| Reperfusion Injury | 2 | 2011 | 144 | 0.400 |
Why?
|
| Quality of Life | 6 | 2007 | 1680 | 0.400 |
Why?
|
| Organ Preservation | 1 | 2013 | 119 | 0.390 |
Why?
|
| Bacterial Proteins | 7 | 2020 | 901 | 0.390 |
Why?
|
| Cell Line | 8 | 2017 | 2495 | 0.390 |
Why?
|
| Siderophores | 1 | 2011 | 22 | 0.390 |
Why?
|
| Survival Analysis | 4 | 2020 | 1497 | 0.390 |
Why?
|
| Hypoxia | 1 | 2016 | 657 | 0.380 |
Why?
|
| Parenteral Nutrition, Total | 6 | 2021 | 41 | 0.380 |
Why?
|
| Quinolones | 2 | 2012 | 56 | 0.370 |
Why?
|
| Starvation | 4 | 2017 | 23 | 0.370 |
Why?
|
| Endoscopy | 2 | 2021 | 352 | 0.360 |
Why?
|
| Perioperative Care | 2 | 2023 | 171 | 0.360 |
Why?
|
| Membrane Microdomains | 2 | 2011 | 54 | 0.360 |
Why?
|
| Pyocyanine | 4 | 2016 | 12 | 0.350 |
Why?
|
| Therapeutic Irrigation | 3 | 2021 | 60 | 0.350 |
Why?
|
| Endotoxins | 2 | 2005 | 36 | 0.350 |
Why?
|
| Body Mass Index | 11 | 2010 | 776 | 0.350 |
Why?
|
| Gastroplasty | 1 | 2010 | 25 | 0.340 |
Why?
|
| Metabolic Diseases | 2 | 2010 | 50 | 0.340 |
Why?
|
| Fundoplication | 1 | 2010 | 79 | 0.340 |
Why?
|
| Gastrointestinal Motility | 3 | 2016 | 25 | 0.340 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2009 | 41 | 0.330 |
Why?
|
| Enteral Nutrition | 6 | 2021 | 105 | 0.330 |
Why?
|
| Dexamethasone | 4 | 1997 | 343 | 0.330 |
Why?
|
| Bacterial Translocation | 6 | 2013 | 26 | 0.330 |
Why?
|
| Radiation-Protective Agents | 1 | 2009 | 98 | 0.320 |
Why?
|
| Ischemia | 4 | 2018 | 253 | 0.320 |
Why?
|
| Epithelium | 7 | 2013 | 323 | 0.320 |
Why?
|
| Cross Infection | 1 | 2010 | 151 | 0.320 |
Why?
|
| Surgical Staplers | 2 | 2023 | 11 | 0.300 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2008 | 25 | 0.300 |
Why?
|
| Signal Transduction | 5 | 2020 | 3403 | 0.300 |
Why?
|
| Hydrogels | 2 | 2020 | 87 | 0.300 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2017 | 27 | 0.290 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 239 | 0.290 |
Why?
|
| Biomarkers | 3 | 2021 | 1775 | 0.290 |
Why?
|
| Self Concept | 7 | 2007 | 135 | 0.290 |
Why?
|
| Bacterial Typing Techniques | 2 | 2020 | 28 | 0.290 |
Why?
|
| Carcinogenesis | 2 | 2019 | 213 | 0.290 |
Why?
|
| Dynorphins | 1 | 2007 | 14 | 0.280 |
Why?
|
| Vitamin D Deficiency | 1 | 2008 | 104 | 0.280 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 346 | 0.280 |
Why?
|
| United States | 9 | 2024 | 7102 | 0.280 |
Why?
|
| Cytokines | 4 | 2020 | 811 | 0.280 |
Why?
|
| Follow-Up Studies | 7 | 2024 | 3680 | 0.280 |
Why?
|
| Biliopancreatic Diversion | 1 | 2006 | 3 | 0.280 |
Why?
|
| Parenteral Nutrition | 4 | 2021 | 63 | 0.280 |
Why?
|
| Esophagus | 2 | 2021 | 107 | 0.270 |
Why?
|
| Aged | 11 | 2024 | 19240 | 0.270 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 151 | 0.270 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 43 | 0.270 |
Why?
|
| Molecular Weight | 4 | 2013 | 331 | 0.260 |
Why?
|
| Bile | 5 | 1992 | 58 | 0.260 |
Why?
|
| Time Factors | 12 | 2009 | 5357 | 0.260 |
Why?
|
| Vomiting | 1 | 2008 | 195 | 0.260 |
Why?
|
| Intensive Care Units | 4 | 2016 | 398 | 0.260 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 129 | 0.250 |
Why?
|
| Vena Cava Filters | 1 | 2007 | 98 | 0.250 |
Why?
|
| Porins | 1 | 2005 | 21 | 0.250 |
Why?
|
| Device Removal | 1 | 2007 | 168 | 0.250 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 156 | 0.250 |
Why?
|
| Water | 2 | 2006 | 286 | 0.240 |
Why?
|
| Stomach | 2 | 2006 | 111 | 0.240 |
Why?
|
| Genome, Bacterial | 2 | 2020 | 151 | 0.240 |
Why?
|
| Drug Resistance, Microbial | 1 | 2024 | 75 | 0.240 |
Why?
|
| Tryptophan | 1 | 2025 | 97 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 1054 | 0.230 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 1008 | 0.230 |
Why?
|
| Sex Offenses | 1 | 2004 | 13 | 0.230 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 232 | 0.230 |
Why?
|
| Venous Thrombosis | 1 | 2007 | 256 | 0.230 |
Why?
|
| Depression | 6 | 2007 | 513 | 0.230 |
Why?
|
| Digestive System | 4 | 1999 | 42 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2415 | 0.230 |
Why?
|
| Inflammation | 4 | 2019 | 981 | 0.230 |
Why?
|
| Immunoglobulin A | 3 | 1999 | 83 | 0.220 |
Why?
|
| Awareness | 1 | 2024 | 88 | 0.220 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 61 | 0.220 |
Why?
|
| Peptide YY | 1 | 2023 | 9 | 0.220 |
Why?
|
| Paneth Cells | 1 | 2023 | 10 | 0.220 |
Why?
|
| Judgment | 1 | 2024 | 67 | 0.220 |
Why?
|
| Sample Size | 1 | 2024 | 125 | 0.220 |
Why?
|
| Candida | 1 | 2023 | 18 | 0.220 |
Why?
|
| Adenosine | 1 | 2006 | 240 | 0.220 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 2022 | 51 | 0.220 |
Why?
|
| Interferon-gamma | 1 | 2005 | 449 | 0.220 |
Why?
|
| Oligopeptides | 2 | 2016 | 188 | 0.220 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 1452 | 0.220 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2025 | 177 | 0.220 |
Why?
|
| Necrosis | 3 | 2012 | 210 | 0.220 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 6780 | 0.210 |
Why?
|
| Administration, Oral | 2 | 2018 | 666 | 0.210 |
Why?
|
| Antifungal Agents | 1 | 2023 | 123 | 0.210 |
Why?
|
| Models, Biological | 5 | 2013 | 1765 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2009 | 2677 | 0.210 |
Why?
|
| Tight Junctions | 4 | 2012 | 150 | 0.200 |
Why?
|
| Enterobacteriaceae | 2 | 2014 | 22 | 0.200 |
Why?
|
| Surveys and Questionnaires | 5 | 2006 | 2653 | 0.200 |
Why?
|
| Pancreatectomy | 1 | 2023 | 164 | 0.200 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 508 | 0.200 |
Why?
|
| Abdominal Neoplasms | 1 | 2002 | 39 | 0.200 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2012 | 70 | 0.200 |
Why?
|
| Fatty Acids, Volatile | 2 | 2020 | 32 | 0.200 |
Why?
|
| Enema | 1 | 2021 | 39 | 0.200 |
Why?
|
| Taurocholic Acid | 1 | 2021 | 6 | 0.200 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 1158 | 0.190 |
Why?
|
| Phosphate-Binding Proteins | 2 | 2014 | 10 | 0.190 |
Why?
|
| Heat-Shock Proteins | 4 | 2007 | 183 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 885 | 0.190 |
Why?
|
| Research Design | 2 | 2024 | 591 | 0.190 |
Why?
|
| Peptide Fragments | 1 | 2023 | 463 | 0.190 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 280 | 0.180 |
Why?
|
| Proteomics | 2 | 2014 | 232 | 0.180 |
Why?
|
| Punctures | 1 | 2020 | 30 | 0.180 |
Why?
|
| Ligation | 1 | 2020 | 52 | 0.180 |
Why?
|
| Butyric Acid | 1 | 2020 | 11 | 0.180 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 15 | 0.180 |
Why?
|
| Symptom Assessment | 1 | 2020 | 67 | 0.180 |
Why?
|
| Bacteremia | 2 | 2003 | 103 | 0.180 |
Why?
|
| Prospective Studies | 4 | 2023 | 4325 | 0.180 |
Why?
|
| Antibody Formation | 1 | 2020 | 171 | 0.170 |
Why?
|
| Adolescent | 7 | 2017 | 9339 | 0.170 |
Why?
|
| Feeding Behavior | 4 | 2007 | 328 | 0.170 |
Why?
|
| Protective Factors | 1 | 2019 | 23 | 0.170 |
Why?
|
| Biology | 1 | 2020 | 52 | 0.170 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 3024 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 2001 | 166 | 0.170 |
Why?
|
| Peptide Hydrolases | 1 | 2020 | 101 | 0.170 |
Why?
|
| Immunophenotyping | 1 | 2020 | 217 | 0.170 |
Why?
|
| Organic Chemicals | 1 | 2019 | 34 | 0.170 |
Why?
|
| Referral and Consultation | 1 | 2022 | 345 | 0.170 |
Why?
|
| Perception | 1 | 2021 | 179 | 0.170 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 90 | 0.170 |
Why?
|
| Lactobacillus | 2 | 2012 | 21 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 855 | 0.170 |
Why?
|
| Abscess | 2 | 2018 | 94 | 0.170 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2019 | 122 | 0.160 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 39 | 0.160 |
Why?
|
| Fimbriae Proteins | 1 | 1999 | 15 | 0.160 |
Why?
|
| Fimbriae, Bacterial | 1 | 1999 | 24 | 0.160 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2018 | 13 | 0.160 |
Why?
|
| Proteolysis | 1 | 2019 | 114 | 0.160 |
Why?
|
| Microscopy, Electron | 3 | 2014 | 511 | 0.160 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 1221 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 311 | 0.160 |
Why?
|
| Genomics | 2 | 2018 | 778 | 0.160 |
Why?
|
| Adaptation, Physiological | 2 | 2016 | 318 | 0.160 |
Why?
|
| Staphylococcus | 2 | 2017 | 24 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 160 | 0.160 |
Why?
|
| Bacterial Physiological Phenomena | 2 | 2004 | 42 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 191 | 0.150 |
Why?
|
| Infant Formula | 3 | 2013 | 17 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 245 | 0.150 |
Why?
|
| Abdominal Injuries | 2 | 2017 | 52 | 0.150 |
Why?
|
| Pancreas | 1 | 2000 | 253 | 0.150 |
Why?
|
| Interleukin-6 | 1 | 2019 | 261 | 0.150 |
Why?
|
| Infant | 3 | 2013 | 3189 | 0.150 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2016 | 91 | 0.150 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2011 | 503 | 0.150 |
Why?
|
| CD24 Antigen | 1 | 2017 | 6 | 0.150 |
Why?
|
| Drug Combinations | 1 | 2018 | 203 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 125 | 0.150 |
Why?
|
| Physician-Patient Relations | 1 | 2023 | 624 | 0.150 |
Why?
|
| Gelatinases | 1 | 2017 | 10 | 0.150 |
Why?
|
| Cholecystokinin | 1 | 1997 | 15 | 0.150 |
Why?
|
| Rats, Inbred F344 | 7 | 1997 | 154 | 0.150 |
Why?
|
| Glucocorticoids | 2 | 1999 | 357 | 0.150 |
Why?
|
| Career Choice | 1 | 2019 | 148 | 0.150 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 38 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 571 | 0.140 |
Why?
|
| Culture Media | 1 | 2017 | 147 | 0.140 |
Why?
|
| Genes, Bacterial | 2 | 2013 | 198 | 0.140 |
Why?
|
| Composite Resins | 1 | 2017 | 4 | 0.140 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2010 | 163 | 0.140 |
Why?
|
| Cell Shape | 1 | 2017 | 51 | 0.140 |
Why?
|
| Cell Hypoxia | 3 | 2011 | 173 | 0.140 |
Why?
|
| Fires | 1 | 2017 | 21 | 0.140 |
Why?
|
| Ileus | 1 | 2017 | 9 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 200 | 0.140 |
Why?
|
| Gastric Mucosa | 3 | 2012 | 68 | 0.140 |
Why?
|
| Chromosome Mapping | 1 | 2020 | 1074 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 175 | 0.140 |
Why?
|
| Moths | 1 | 2017 | 32 | 0.140 |
Why?
|
| General Surgery | 2 | 2011 | 236 | 0.140 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 146 | 0.140 |
Why?
|
| Disinfection | 1 | 2016 | 15 | 0.140 |
Why?
|
| Symbiosis | 2 | 2023 | 127 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 118 | 0.140 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 258 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 151 | 0.140 |
Why?
|
| Neutrophils | 1 | 2018 | 311 | 0.130 |
Why?
|
| Metronidazole | 1 | 2016 | 26 | 0.130 |
Why?
|
| Chloramines | 3 | 2012 | 20 | 0.130 |
Why?
|
| Patient Selection | 3 | 2010 | 682 | 0.130 |
Why?
|
| Intestine, Large | 1 | 1996 | 15 | 0.130 |
Why?
|
| Metagenomics | 2 | 2014 | 92 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1083 | 0.130 |
Why?
|
| Computer Simulation | 4 | 2013 | 1102 | 0.130 |
Why?
|
| Disease Progression | 1 | 2020 | 1469 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 1929 | 0.130 |
Why?
|
| Energy Metabolism | 1 | 2018 | 282 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2016 | 91 | 0.130 |
Why?
|
| Base Sequence | 2 | 2012 | 2329 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 131 | 0.130 |
Why?
|
| Physicians | 1 | 2023 | 691 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 167 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 222 | 0.130 |
Why?
|
| Interleukin-10 | 1 | 2016 | 155 | 0.120 |
Why?
|
| Abdominal Muscles | 1 | 2015 | 19 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2017 | 793 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 1996 | 138 | 0.120 |
Why?
|
| Swine | 3 | 2012 | 590 | 0.120 |
Why?
|
| Sleep Wake Disorders | 1 | 1996 | 118 | 0.120 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 178 | 0.120 |
Why?
|
| Cells, Cultured | 5 | 2013 | 2887 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2016 | 164 | 0.120 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 1994 | 4 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2015 | 95 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2006 | 274 | 0.120 |
Why?
|
| Drug Resistance, Fungal | 1 | 2014 | 8 | 0.120 |
Why?
|
| Cathartics | 1 | 2014 | 27 | 0.120 |
Why?
|
| Electric Impedance | 3 | 2008 | 111 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2016 | 2327 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2007 | 262 | 0.120 |
Why?
|
| Oxidative Stress | 3 | 2013 | 458 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 160 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 434 | 0.120 |
Why?
|
| Enterococcus | 1 | 2014 | 35 | 0.120 |
Why?
|
| Caspase 3 | 2 | 2011 | 162 | 0.120 |
Why?
|
| Animal Feed | 2 | 2013 | 20 | 0.120 |
Why?
|
| Hospitals | 1 | 2017 | 303 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2009 | 1237 | 0.120 |
Why?
|
| Homeostasis | 1 | 2016 | 418 | 0.120 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 113 | 0.120 |
Why?
|
| Immunocompetence | 1 | 1994 | 26 | 0.120 |
Why?
|
| Cell Membrane Structures | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cell Surface Extensions | 1 | 2014 | 11 | 0.110 |
Why?
|
| Nicotine | 1 | 2016 | 200 | 0.110 |
Why?
|
| DNA, Bacterial | 3 | 2010 | 244 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 869 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 82 | 0.110 |
Why?
|
| Aerobiosis | 1 | 2013 | 17 | 0.110 |
Why?
|
| Milk Substitutes | 1 | 2013 | 2 | 0.110 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 114 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 358 | 0.110 |
Why?
|
| Cold Ischemia | 1 | 2013 | 19 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2017 | 434 | 0.110 |
Why?
|
| Organ Preservation Solutions | 1 | 2013 | 31 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 399 | 0.110 |
Why?
|
| Microdissection | 2 | 2010 | 18 | 0.110 |
Why?
|
| Glutamine | 2 | 1990 | 79 | 0.110 |
Why?
|
| Smoking | 1 | 2017 | 625 | 0.110 |
Why?
|
| Neoplasms | 3 | 2019 | 3065 | 0.100 |
Why?
|
| Contrast Media | 2 | 2009 | 1084 | 0.100 |
Why?
|
| Radiation | 1 | 2012 | 15 | 0.100 |
Why?
|
| Cryopreservation | 1 | 2013 | 70 | 0.100 |
Why?
|
| Milk, Human | 1 | 2013 | 46 | 0.100 |
Why?
|
| Tosyl Compounds | 1 | 2012 | 13 | 0.100 |
Why?
|
| Patient Care Team | 2 | 2006 | 284 | 0.100 |
Why?
|
| Choledochostomy | 1 | 2012 | 8 | 0.100 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1992 | 47 | 0.100 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 78 | 0.100 |
Why?
|
| Protective Agents | 1 | 2012 | 34 | 0.100 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 34 | 0.100 |
Why?
|
| Double-Blind Method | 1 | 2016 | 1714 | 0.100 |
Why?
|
| Deoxycholic Acid | 1 | 2011 | 10 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 136 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2017 | 2887 | 0.100 |
Why?
|
| Peritoneal Lavage | 2 | 1988 | 12 | 0.100 |
Why?
|
| Permeability | 4 | 2004 | 138 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2012 | 73 | 0.100 |
Why?
|
| Neoplasm Proteins | 2 | 2005 | 538 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2011 | 899 | 0.100 |
Why?
|
| Oxygen | 2 | 2011 | 745 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 2587 | 0.100 |
Why?
|
| Young Adult | 2 | 2017 | 6408 | 0.100 |
Why?
|
| Benzhydryl Compounds | 1 | 2011 | 44 | 0.100 |
Why?
|
| Dietary Proteins | 1 | 2011 | 30 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2011 | 39 | 0.100 |
Why?
|
| Microbiological Techniques | 1 | 2011 | 24 | 0.090 |
Why?
|
| Fungal Proteins | 1 | 2012 | 142 | 0.090 |
Why?
|
| Abdominal Pain | 2 | 2009 | 142 | 0.090 |
Why?
|
| Abdomen | 2 | 1988 | 124 | 0.090 |
Why?
|
| Ventricular Function | 1 | 2011 | 53 | 0.090 |
Why?
|
| Esophageal Fistula | 1 | 1990 | 11 | 0.090 |
Why?
|
| Fasting | 1 | 2011 | 162 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 245 | 0.090 |
Why?
|
| Carotid Artery Injuries | 1 | 1990 | 22 | 0.090 |
Why?
|
| Vitamins | 1 | 2011 | 83 | 0.090 |
Why?
|
| Genetic Techniques | 1 | 2011 | 73 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 283 | 0.090 |
Why?
|
| Jejunal Diseases | 1 | 2010 | 10 | 0.090 |
Why?
|
| Microclimate | 1 | 2010 | 4 | 0.090 |
Why?
|
| Reference Values | 1 | 2011 | 662 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2007 | 785 | 0.090 |
Why?
|
| Drug Design | 1 | 2011 | 126 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 326 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 2011 | 261 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2011 | 184 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 201 | 0.090 |
Why?
|
| Iohexol | 1 | 2009 | 24 | 0.090 |
Why?
|
| Diatrizoate Meglumine | 1 | 2009 | 19 | 0.090 |
Why?
|
| Diverticulum | 1 | 2010 | 45 | 0.090 |
Why?
|
| Brain | 1 | 2020 | 2304 | 0.090 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2009 | 17 | 0.090 |
Why?
|
| Personal Satisfaction | 1 | 2010 | 64 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 1990 | 99 | 0.080 |
Why?
|
| Hernia, Ventral | 1 | 2009 | 25 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2012 | 288 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2012 | 498 | 0.080 |
Why?
|
| Fluoroscopy | 1 | 2009 | 127 | 0.080 |
Why?
|
| Blood Transfusion | 1 | 2010 | 171 | 0.080 |
Why?
|
| Clostridium Infections | 1 | 2011 | 125 | 0.080 |
Why?
|
| Depressive Disorder | 2 | 2007 | 221 | 0.080 |
Why?
|
| Mothers | 1 | 2010 | 145 | 0.080 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 89 | 0.080 |
Why?
|
| HSP72 Heat-Shock Proteins | 2 | 2005 | 23 | 0.080 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 760 | 0.080 |
Why?
|
| Cues | 1 | 2010 | 174 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2006 | 1729 | 0.080 |
Why?
|
| Wounds, Gunshot | 1 | 1990 | 99 | 0.080 |
Why?
|
| Color | 1 | 2009 | 85 | 0.080 |
Why?
|
| Indiana | 1 | 2008 | 14 | 0.080 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1988 | 4 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2006 | 272 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 919 | 0.080 |
Why?
|
| Gastrostomy | 2 | 2006 | 70 | 0.080 |
Why?
|
| Biodiversity | 1 | 2010 | 209 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2012 | 1227 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1983 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 314 | 0.070 |
Why?
|
| Actins | 2 | 2008 | 462 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1859 | 0.070 |
Why?
|
| Enterocytes | 2 | 2004 | 26 | 0.070 |
Why?
|
| Shock | 1 | 2007 | 44 | 0.070 |
Why?
|
| Longevity | 1 | 2008 | 58 | 0.070 |
Why?
|
| Cholesterol | 1 | 2009 | 360 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2007 | 13 | 0.070 |
Why?
|
| Prevalence | 3 | 2008 | 1250 | 0.070 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2007 | 10 | 0.070 |
Why?
|
| Software | 1 | 2011 | 669 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 591 | 0.070 |
Why?
|
| Child | 3 | 2017 | 7242 | 0.070 |
Why?
|
| Reoperation | 1 | 2009 | 604 | 0.070 |
Why?
|
| Syndrome | 1 | 2007 | 450 | 0.070 |
Why?
|
| Prejudice | 1 | 2007 | 48 | 0.070 |
Why?
|
| Feeding and Eating Disorders | 1 | 2009 | 182 | 0.070 |
Why?
|
| Illinois | 1 | 2008 | 485 | 0.070 |
Why?
|
| Inosine | 1 | 2006 | 19 | 0.070 |
Why?
|
| DNA Fingerprinting | 1 | 2006 | 16 | 0.070 |
Why?
|
| Gentamicins | 1 | 2006 | 20 | 0.070 |
Why?
|
| Neurosecretory Systems | 2 | 1999 | 36 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 474 | 0.070 |
Why?
|
| Peristalsis | 1 | 2006 | 10 | 0.070 |
Why?
|
| Bulimia Nervosa | 1 | 2007 | 109 | 0.070 |
Why?
|
| Barium Sulfate | 1 | 2006 | 43 | 0.070 |
Why?
|
| Manometry | 1 | 2006 | 44 | 0.070 |
Why?
|
| Comorbidity | 1 | 2010 | 953 | 0.070 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 157 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2007 | 299 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2007 | 287 | 0.060 |
Why?
|
| Specialization | 1 | 2006 | 70 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2008 | 464 | 0.060 |
Why?
|
| DNA Primers | 1 | 2006 | 543 | 0.060 |
Why?
|
| Catheterization | 1 | 2006 | 237 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2012 | 871 | 0.060 |
Why?
|
| DNA, Complementary | 3 | 2013 | 391 | 0.060 |
Why?
|
| Motivation | 1 | 2007 | 296 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 226 | 0.060 |
Why?
|
| Cytoprotection | 1 | 2004 | 47 | 0.060 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2004 | 41 | 0.060 |
Why?
|
| Transfection | 1 | 2006 | 909 | 0.060 |
Why?
|
| Aorta | 1 | 2006 | 289 | 0.060 |
Why?
|
| Proteins | 2 | 2006 | 786 | 0.060 |
Why?
|
| Lymph Nodes | 4 | 1992 | 550 | 0.060 |
Why?
|
| Movement | 1 | 2006 | 311 | 0.060 |
Why?
|
| Lung | 2 | 2008 | 1292 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 1066 | 0.060 |
Why?
|
| Cell Survival | 1 | 2006 | 983 | 0.060 |
Why?
|
| Mesentery | 3 | 1992 | 45 | 0.060 |
Why?
|
| Emotions | 1 | 2007 | 354 | 0.050 |
Why?
|
| Jejunum | 3 | 2012 | 80 | 0.050 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 219 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2004 | 212 | 0.050 |
Why?
|
| Electrophysiology | 2 | 2004 | 403 | 0.050 |
Why?
|
| Nutritional Requirements | 1 | 2002 | 17 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 726 | 0.050 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2002 | 77 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 754 | 0.050 |
Why?
|
| Trust | 1 | 2023 | 97 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2006 | 584 | 0.050 |
Why?
|
| Principal Component Analysis | 2 | 2013 | 161 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 654 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 771 | 0.050 |
Why?
|
| Protein Binding | 1 | 2005 | 1491 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 71 | 0.050 |
Why?
|
| Mannitol | 1 | 2001 | 50 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2002 | 112 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2012 | 2498 | 0.050 |
Why?
|
| Clinical Decision-Making | 1 | 2023 | 280 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2020 | 71 | 0.050 |
Why?
|
| Kidney | 1 | 2006 | 1148 | 0.040 |
Why?
|
| Exotoxins | 1 | 2000 | 20 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 2000 | 50 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2013 | 524 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2021 | 314 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 105 | 0.040 |
Why?
|
| Surface Properties | 1 | 2020 | 131 | 0.040 |
Why?
|
| Work of Breathing | 1 | 1999 | 5 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 123 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 126 | 0.040 |
Why?
|
| Biological Transport | 2 | 2004 | 401 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2001 | 205 | 0.040 |
Why?
|
| Body Weight | 1 | 2001 | 453 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 476 | 0.040 |
Why?
|
| Ion Transport | 1 | 1999 | 85 | 0.040 |
Why?
|
| Mental Health | 1 | 2001 | 180 | 0.040 |
Why?
|
| Adhesins, Escherichia coli | 1 | 1999 | 3 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1864 | 0.040 |
Why?
|
| Infliximab | 1 | 2020 | 159 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 1999 | 70 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2001 | 494 | 0.040 |
Why?
|
| Gastrointestinal Contents | 2 | 2011 | 5 | 0.040 |
Why?
|
| Drainage | 1 | 2000 | 165 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 490 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 469 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 1999 | 245 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2001 | 291 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2020 | 191 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2767 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1990 | 312 | 0.040 |
Why?
|
| Acute Disease | 1 | 2000 | 846 | 0.040 |
Why?
|
| Living Donors | 1 | 2001 | 339 | 0.040 |
Why?
|
| Propionibacterium | 1 | 2017 | 6 | 0.040 |
Why?
|
| Decision Making | 1 | 2023 | 670 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1988 | 374 | 0.040 |
Why?
|
| Electric Conductivity | 2 | 1995 | 144 | 0.040 |
Why?
|
| DNA Damage | 1 | 2019 | 373 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2002 | 523 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 1999 | 341 | 0.030 |
Why?
|
| Sleep, REM | 1 | 1996 | 51 | 0.030 |
Why?
|
| Intestinal Absorption | 2 | 2002 | 125 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 1997 | 224 | 0.030 |
Why?
|
| Body Temperature | 1 | 1997 | 125 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 1997 | 140 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1996 | 14 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1996 | 39 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2002 | 684 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1997 | 436 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2007 | 281 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 755 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 116 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2017 | 381 | 0.030 |
Why?
|
| ras Proteins | 1 | 2016 | 130 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 177 | 0.030 |
Why?
|
| Locomotion | 1 | 2016 | 140 | 0.030 |
Why?
|
| Negative Staining | 1 | 2014 | 2 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 182 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2016 | 199 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2014 | 29 | 0.030 |
Why?
|
| Genotype | 1 | 1999 | 1853 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2001 | 856 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 1731 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 1994 | 29 | 0.030 |
Why?
|
| Pressure | 1 | 1994 | 167 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 2013 | 31 | 0.030 |
Why?
|
| Proteus mirabilis | 1 | 1992 | 4 | 0.030 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2012 | 23 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 1992 | 46 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 33 | 0.030 |
Why?
|
| Gene Library | 1 | 2013 | 132 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2012 | 1533 | 0.030 |
Why?
|
| Histology | 1 | 2012 | 4 | 0.030 |
Why?
|
| Temperature | 1 | 1994 | 409 | 0.030 |
Why?
|
| Calibration | 1 | 2012 | 103 | 0.030 |
Why?
|
| Biomedical Engineering | 1 | 2012 | 20 | 0.030 |
Why?
|
| Cholangiography | 1 | 2012 | 43 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2004 | 2026 | 0.030 |
Why?
|
| Sodium | 2 | 2004 | 333 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 371 | 0.030 |
Why?
|
| Bile Ducts | 1 | 2012 | 60 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 423 | 0.030 |
Why?
|
| Suture Techniques | 1 | 2013 | 144 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2012 | 278 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2012 | 20 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 2063 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2011 | 42 | 0.020 |
Why?
|
| Incidence | 2 | 2013 | 1601 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2011 | 95 | 0.020 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1991 | 22 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2002 | 80 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 76 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 996 | 0.020 |
Why?
|
| Vancomycin | 1 | 2011 | 73 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 422 | 0.020 |
Why?
|
| Forearm | 1 | 1990 | 31 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2010 | 46 | 0.020 |
Why?
|
| Rhabdomyolysis | 1 | 1990 | 28 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 40 | 0.020 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2011 | 58 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2011 | 105 | 0.020 |
Why?
|
| Human Experimentation | 1 | 2010 | 39 | 0.020 |
Why?
|
| Gestational Age | 1 | 2011 | 329 | 0.020 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2010 | 19 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 376 | 0.020 |
Why?
|
| Calcium | 2 | 1995 | 1179 | 0.020 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2010 | 52 | 0.020 |
Why?
|
| Connective Tissue Diseases | 1 | 1990 | 70 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 93 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1990 | 135 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 371 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 682 | 0.020 |
Why?
|
| Ecology | 1 | 1990 | 76 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2011 | 299 | 0.020 |
Why?
|
| Calcinosis | 1 | 1990 | 231 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 412 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2008 | 34 | 0.020 |
Why?
|
| Thrombin | 1 | 2008 | 61 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 137 | 0.020 |
Why?
|
| Adherens Junctions | 1 | 2008 | 34 | 0.020 |
Why?
|
| Secretory Rate | 1 | 1988 | 13 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 469 | 0.020 |
Why?
|
| Laparotomy | 1 | 1988 | 68 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 700 | 0.020 |
Why?
|
| Autopsy | 1 | 1988 | 122 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1988 | 223 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2008 | 64 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2008 | 138 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 421 | 0.020 |
Why?
|
| Solute Carrier Family 22 Member 5 | 1 | 2007 | 5 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 661 | 0.020 |
Why?
|
| Contraindications | 1 | 2007 | 70 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2007 | 18 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2008 | 195 | 0.020 |
Why?
|
| Spleen | 1 | 1988 | 433 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 114 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 1898 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 91 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2010 | 490 | 0.020 |
Why?
|
| Life Style | 1 | 2007 | 176 | 0.020 |
Why?
|
| Hunger | 1 | 2006 | 23 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1990 | 316 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1669 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 183 | 0.020 |
Why?
|
| North America | 1 | 2006 | 188 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1075 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 103 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 123 | 0.020 |
Why?
|
| Fermentation | 1 | 2004 | 13 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 198 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2004 | 33 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 1984 | 38 | 0.010 |
Why?
|
| Phylogeny | 1 | 2010 | 1197 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 3796 | 0.010 |
Why?
|
| Probiotics | 1 | 2005 | 89 | 0.010 |
Why?
|
| Lasers | 1 | 2004 | 107 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 293 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 696 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 595 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 341 | 0.010 |
Why?
|
| Hematoma | 1 | 1984 | 108 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 278 | 0.010 |
Why?
|
| Marital Status | 1 | 2003 | 42 | 0.010 |
Why?
|
| RNA Interference | 1 | 2004 | 376 | 0.010 |
Why?
|
| Liver | 1 | 1988 | 1211 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 693 | 0.010 |
Why?
|
| Employment | 1 | 2003 | 53 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1908 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 2002 | 35 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 1 | 2002 | 33 | 0.010 |
Why?
|
| Microvilli | 1 | 2002 | 43 | 0.010 |
Why?
|
| Child Nutrition Disorders | 1 | 2002 | 12 | 0.010 |
Why?
|
| Hydrolases | 1 | 2002 | 30 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 195 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 557 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 258 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 199 | 0.010 |
Why?
|
| Peptides | 1 | 2005 | 649 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 1130 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2002 | 212 | 0.010 |
Why?
|
| Global Health | 1 | 2002 | 193 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2000 | 24 | 0.010 |
Why?
|
| Dissection | 1 | 2001 | 44 | 0.010 |
Why?
|
| Hyperoxia | 1 | 2000 | 35 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 2000 | 47 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 583 | 0.010 |
Why?
|
| Urine | 1 | 2000 | 92 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 1999 | 40 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 217 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2002 | 678 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2002 | 364 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 1999 | 358 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 1311 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2002 | 744 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 117 | 0.010 |
Why?
|
| Personnel, Hospital | 1 | 1991 | 30 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 1991 | 60 | 0.010 |
Why?
|
| Dialysis Solutions | 1 | 1990 | 7 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1991 | 55 | 0.010 |
Why?
|
| Hypocalcemia | 1 | 1990 | 44 | 0.010 |
Why?
|
| Trauma Centers | 1 | 1991 | 148 | 0.010 |
Why?
|
| Dogs | 1 | 1988 | 706 | 0.000 |
Why?
|
| Chicago | 1 | 1991 | 1431 | 0.000 |
Why?
|
| Pelvic Bones | 1 | 1984 | 43 | 0.000 |
Why?
|
| Wounds, Penetrating | 1 | 1984 | 56 | 0.000 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1984 | 113 | 0.000 |
Why?
|
| Fractures, Bone | 1 | 1984 | 133 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1984 | 162 | 0.000 |
Why?
|